| Dr Vijay Seelall, MD | |
|
300 Madison Ave, Madison, NJ 07940-1868 | |
| (973) 822-2772 | |
| (973) 822-2773 |
| Full Name | Dr Vijay Seelall |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 24 Years |
| Location | 300 Madison Ave, Madison, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821219171 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RS0012X | Internal Medicine - Sleep Medicine | 25MA09035100 (New Jersey) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 25MA09035100 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlook Medical Center | Summit, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group Pa | 5395642276 | 1253 |
News Archive
NPR's "Tell Me More" on Thursday included a discussion with Brazil's HIV/AIDS program director Mariangela Simao. Simao discussed progress in Brazil's no-cost antiretroviral program and the country's efforts to collaborate with Portuguese-speaking countries in Africa on HIV prevention.
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.
DigiPath Labs of Las Vegas, a subsidiary of DigiPath, Inc., has entered into a one-year agreement with Euphoria Wellness to conduct comprehensive safety and potency tests on the products Euphoria will sell in its Las Vegas medical marijuana dispensary.
› Verified 2 days ago
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
NPR's "Tell Me More" on Thursday included a discussion with Brazil's HIV/AIDS program director Mariangela Simao. Simao discussed progress in Brazil's no-cost antiretroviral program and the country's efforts to collaborate with Portuguese-speaking countries in Africa on HIV prevention.
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.
DigiPath Labs of Las Vegas, a subsidiary of DigiPath, Inc., has entered into a one-year agreement with Euphoria Wellness to conduct comprehensive safety and potency tests on the products Euphoria will sell in its Las Vegas medical marijuana dispensary.
› Verified 2 days ago
| Entity Name | Advocare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
NPR's "Tell Me More" on Thursday included a discussion with Brazil's HIV/AIDS program director Mariangela Simao. Simao discussed progress in Brazil's no-cost antiretroviral program and the country's efforts to collaborate with Portuguese-speaking countries in Africa on HIV prevention.
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.
DigiPath Labs of Las Vegas, a subsidiary of DigiPath, Inc., has entered into a one-year agreement with Euphoria Wellness to conduct comprehensive safety and potency tests on the products Euphoria will sell in its Las Vegas medical marijuana dispensary.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vijay Seelall, MD 300 Madison Ave Fl 3, Madison, NJ 07940-1868 Ph: (973) 822-2772 | Dr Vijay Seelall, MD 300 Madison Ave, Madison, NJ 07940-1868 Ph: (973) 822-2772 |
News Archive
NPR's "Tell Me More" on Thursday included a discussion with Brazil's HIV/AIDS program director Mariangela Simao. Simao discussed progress in Brazil's no-cost antiretroviral program and the country's efforts to collaborate with Portuguese-speaking countries in Africa on HIV prevention.
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.
DigiPath Labs of Las Vegas, a subsidiary of DigiPath, Inc., has entered into a one-year agreement with Euphoria Wellness to conduct comprehensive safety and potency tests on the products Euphoria will sell in its Las Vegas medical marijuana dispensary.
› Verified 2 days ago
Marc L Benton, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Madison Ave, Suite 201, Madison, NJ 07940 Phone: 973-822-2772 Fax: 973-822-2773 | |
Dr. Vincent Anthony Esposito, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 322 Main St, Madison, NJ 07940 Phone: 973-301-2471 Fax: 973-301-0757 | |
Madiha Latif, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 89 Fairfax Ct, Madison, NJ 07940 Phone: 973-647-2866 | |
Traian Parvulescu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8 Shunpike Rd, Madison, NJ 07940 Phone: 973-377-6216 Fax: 973-829-1562 | |
Mary Elisabeth Harris, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Madison Ave Fl 3, Madison, NJ 07940 Phone: 973-822-2772 | |
Dr. Hany Abdallah, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 27 Elm St Apt 3, Madison, NJ 07940 Phone: 973-443-0052 |